STAT+: ‘It’s beyond unethical’: Opaque conflicts of interest permeate prescription drug benefits
A largely hidden flow of money between major consulting conglomerates and PBMs compromises the firms’ ability to choose prescription drug benefits for employers.
Employers across the country — from big names like Boeing and UPS to local school systems — pay consulting firms to handle a straightforward task with their prescription drug coverage: Get the best deals possible, and make sure the industry’s middlemen, known as pharmacy benefit managers,
